Skip to main content
. 2014 Dec;9(2):65–70. doi: 10.15420/ecr.2014.9.2.65

Figure 1: PCSK9, LDL-P and LDL-R Cellular Metabolism.

Figure 1:

PCSK 9 enters the secretory pathway through the Golgi network. Circulating PCSK9 binds to LDL-R on cellular surface of hepatocytes. Bound LDL-P to LDL-R is internalised along with PCSK9. In the endosome, the bound PCSK9 targets LDL-R in the endosome for degradation, subsequently lowering LDL-R levels and increasing circulating LDL-P and LDL-C. LDL-R = LDL receptor; LDL-P = LDL particle.